Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?

“Even from a somewhat self-interested perspective, it’s shortsighted and counterproductive not to ensure access to these medicines,” Professor Brook Baker ’76, senior policy analyst for Health GAP, tells The New York Times .